Mycoplasma Contamination of Cell Lines and the Impact on the Development and Manufacture of Biologicals and Pharmaceuticals

This training program will help attendees understand the sources of mycoplasma contamination and how to minimize the occurrence of contamination. The regulatory standards for testing will be described as well as the methods of mycoplasma detection and the resources for testing.

Why Should You Attend:

If you use continually passaged cell lines for the production of biologics in a pharmaceutical or biotechnology setting and you do not currently test for mycoplasma contamination, awareness for the need for this testing of contamination should not be ignored or overlooked.

Who Will Benefit:

This webinar will benefit those in the pharmaceutical, biotechnology and medical device industries that are using continually passaged cell lines for production of biologics and are not currently testing for mycoplasma contamination.

Research and development managers, supervisors and technicians

Manufacturing managers, supervisors and technicians

Quality control managers, supervisors and technicians

Instructor Profile:

Michael Simonian, Ph.D., has over 30 years of experience in both basic research in academia and industry product development. Dr. Simonian owns MHS Biotechnology Consulting, a company that provides consultation and onsite laboratory services to medical device, pharmaceutical and biotechnology companies that range from start-ups to established multinational companies.

Note:

Use coupon code NB5SQH8N and get 10% off on registration, Valid till Dec 31st 2015.

For Registration:

http://www.complianceonline.com/mycoplasma-contamination-of-cell-lines-and-its-impact-on-biologicals-and-pharmaceuticals-webinar-training-704185-prdw?channel=sciencedz